Jonathan Gaik received his BS in Chemistry from the Missouri University of Science and Technology (Rolla, MO, US). He has worked in solid oral dosage formulation and process development in the pharmaceutical and food industries. Mr Gaik has various patent applications for his work combating the opioid crisis via abuse-deterrent dosage forms. His current interest is driving the development of continuous manufacturing and identifying first principles sources of solid oral dosage formulation-related issues during processing. Mr Gaik is currently director of Natoli Scientific and co-director of the Natoli Institute for Industrial Pharmacy Research and Development at the Arnold and Marie Schwartz School of Pharmacy at Long Island University (NY, US).